Glox Theraputics

Developer of precision antibiotics to target antimicrobial resistant pathogens

placeGlasgow, Scotland, United Kingdom calendar_todayFounded 2023 language gloxtherapeutics.com

Registered entities

Social engagement

Social engagement: 1.3K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record; lead investors include Boehringer Ingelheim Venture Fund, Scottish Enterprise.

Investor typeCountShare
Venture capital133%
Other / undisclosed267%

Recent activity

25 Jun 2026
Recognition
Coming soon